| BIIB | Biogen Inc | 2.40% |
| JAZZ | Jazz Pharmaceuticals PLC | 2.25% |
| ABBV | AbbVie Inc | 2.22% |
| CPRI.L | Capri Holdings Ltd | 2.21% |
| UNH | UnitedHealth Group Inc | 2.20% |
| NTAP | NetApp Inc | 2.19% |
| UTHR | United Therapeutics Corp | 2.19% |
| DISCA | Discovery Inc Class A | 2.18% |
| FOXA | Fox Corp Class A | 2.14% |
| LRCX | Lam Research Corp | 2.14% |
The investment seeks to track the performance, before fees and expenses, of the Aptus Fortified Value Index (the "index"). Under normal circumstances, at least 80% of the fund's total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the index. The index is a rules-based, equal-weighted index that is designed to gain exposure to 50 of the most undervalued U.S.-listed common stocks and real estate investment trusts ("REITs"), while hedging against significant U.S. equity market declines when the market is overvalued. The fund is non-diversified.
Aptus Fortified Value ETF
No recent news for FTVA. The ingest cron pulls every 15 minutes during market hours.